CClinicalTrials.gg
CompletedNCT07067684Updated Sep 15, 2026

LTV (Low Tidal Volüme) Ventilation and Diaphragmatic Motion in CABG (Coronary Artery Bypass Grafting)

An interventional study of Low Tidal Volume Ventilation During CPB in Perioperative Respiratory Function, Diaphragmatic Dysfunction and Low Tidal Volume Ventilation, sponsored by Konya City Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Konya City Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate whether low tidal volume (LTV) ventilation during cardiopulmonary bypass (CPB) surgery helps preserve diaphragmatic excursion in adult patients undergoing coronary artery bypass grafting (CABG). The study will also assess the relationship between LTV ventilation and postoperative pulmonary complications, such as atelectasis, pleural effusion, and pneumonia.

The main questions this trial aims to answer are:

Does LTV ventilation better preserve diaphragmatic motion compared to apnea during CPB?

Are postoperative pulmonary complications less frequent in patients receiving LTV?

Does LTV contribute to shorter extubation times and ICU stays?

Researchers will compare LTV ventilation with apnea (standard care) during CPB to assess its effects on diaphragmatic excursion, measured via ultrasound, and postoperative respiratory outcomes.

Participants will:

Undergo elective CABG surgery under general anesthesia

Be randomly assigned to receive either LTV ventilation or apnea during CPB

Have diaphragmatic excursion measured by ultrasound before surgery, before extubation, and 24 hours after surgery

Be monitored for postoperative pulmonary complications (atelectasis, effusion, pneumonia), extubation time, and ICU length of stay

Ultrasound will be used to measure diaphragmatic excursion (DE) in quiet and deep breathing. DE below 10 mm will be considered as diaphragmatic paralysis. Postoperative respiratory assessments will include blood gas analysis (PaO₂/FiO₂ ratio), clinical respiratory parameters, and imaging findings.

This is a prospective, single-center, assessor-blinded randomized controlled trial. Patients and outcome assessors will be blinded to group allocation. The study will be conducted at the Anesthesiology Clinic of Konya City Hospital and is expected to enroll 60 patients.

Read the detailed description

oronary artery bypass grafting (CABG) surgery performed under cardiopulmonary bypass (CPB) is a complex procedure frequently associated with postoperative pulmonary complications (PPCs). During CPB, mechanical ventilation is usually paused (apnea), which leads to temporary diaphragmatic inactivity. The diaphragm, being a rhythmically contracting muscle under normal physiological conditions, may experience transient dysfunction or even paralysis due to this intraoperative inactivity. Several mechanisms, including loss of neuromechanical coupling, disrupted neuromuscular signaling, altered venous return, and impaired diaphragmatic oxygenation and metabolism, are thought to contribute to this process.

Reduced diaphragmatic motion can create a favorable condition for atelectasis, impair oxygenation, and increase the risk of infection in the postoperative period. The resulting transient diaphragmatic dysfunction is considered a potential contributor to the development of PPCs such as pneumonia, pleural effusion, and prolonged mechanical ventilation.

Recent research has focused on the protective effects of low tidal volume (LTV) ventilation in surgical and critical care settings. However, limited studies have evaluated its direct impact on diaphragmatic function during CPB, particularly in the context of CABG surgery. There is a need to investigate whether intraoperative application of LTV ventilation during CPB can help preserve diaphragmatic excursion (DE) and reduce PPCs.

02

Conditions studied

  • Perioperative Respiratory Function
  • Diaphragmatic Dysfunction
  • Low Tidal Volume Ventilation

Keywords

  • Low Tidal Volume Ventilation
  • Diaphragmatic Excursion
  • Coronary Artery Bypass Grafting (CABG)
03

In context

Lead sponsor

Konya City Hospital is the lead sponsor of 76 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Age over 18 years

Male or female patients

American Society of Anesthesiologists (ASA) physical status class II or III

Scheduled for elective coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB)

Provided written informed consent to participate in the study -

Exclusion criteria

Exclusion Criteria:

History of neuromuscular disease

History of thoracic surgery

History of pneumothorax or ascites

Chronic respiratory failure

Pulmonary hypertension or right ventricular failure

Emergency surgery

Inability to perform diaphragm ultrasonographic measurements

Refusal to participate in the study

-

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Group Low

    Low Tidal Volume Ventilation Group (LTV)

    Other: Low Tidal Volume Ventilation During CPB

  • No intervention
    Group Apnea

    Apnea Group (Control Group)

Interventions

  • OtherLow Tidal Volume Ventilation During CPB

    Group Low: Patients in this group will receive low tidal volume mechanical ventilation during cardiopulmonary bypass (CPB). Ventilation settings will be: Tidal Volume: 3-4 mL/kg (ideal body weight) PEEP: 5-8 cmH₂O Respiratory Rate: adjusted to maintain normocapnia (PaCO₂ 35-45 mmHg)

06

What researchers measure

Primary outcomes

  1. Change in Diaphragmatic Excursion Measured by Ultrasound

    Diaphragmatic excursion (DE) will be measured using M-mode ultrasonography with a 2-5 MHz convex probe placed in the right mid-clavicular subcostal view. Measurements will be performed during both quiet and deep breathing maneuvers. A DE value of ≤10 mm will be considered indicative of diaphragmatic paralysis. The average of three consecutive measurements will be recorded at each time point. The main comparison will assess postoperative DE values between groups receiving low tidal volume ventilation and apnea during CPB.

    Time frame: Baseline (30 minutes before transfer to the operating room (Preoperative baseline) Postoperative ( Immediately Before Extubation) 24 Hours After Surgery (24 hours after the end of surgery)

Secondary outcomes

  1. Incidence of Postoperative Pulmonary Complications

    Time frame: First 3 Days After Surgery and Prior to ICU Discharge

  2. Time to Extubation

    The time from ICU admission to successful extubation will be recorded in hours. Extubation will be performed based on predefined weaning criteria, including neurological status, respiratory stability, hemodynamic parameters, and oxygenation status. Patients not meeting criteria within 24 hours will be recorded accordingly.

    Time frame: From ICU Admission to Extubation (Up to 24 Hours Postoperatively)

07

Study locations

1 site
  • Konya City Hospital
    Konya, Konya 42020, Turkey (Türkiye)
08

References and documents

Publications

  • Barbariol F, Deana C, Guadagnin GM, Cammarota G, Vetrugno L, Bassi F. Ultrasound diaphragmatic excursion during non-invasive ventilation in ICU: a prospective observational study. Acta Biomed. 2021 Jul 1;92(3):e2021269. doi: 10.23750/abm.v92i3.11609. PubMed 34212900 ↗

Individual participant data

Plan to share: No — The plan to share individual participant data has not been determined. No data will be shared at this stage due to institutional policy and ethical concerns.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07067684
Lead sponsor
Konya City Hospital
Responsible party
Nuran Akıncı Ekinci (MD, Anesthesiologist, Department of Anesthesiology, Konya City Hospital) — Principal investigator
First posted
Jul 16, 2025
Start date
Jul 1, 2025
Primary completion
Nov 5, 2025
Completion
Nov 30, 2025
Last update
Sep 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion